Pharmgate announces new appointments.

Dr. James SkinnerĀ is appointed as Director of Clinical Development. James holds MS and PhD degrees in Poultry Science and Poultry Nutrition from Louisiana State and the University of Arkansas and is well acquainted with the industry through his previous career in technical service, clinical research and product development positions with Alpharma and Huvepharma.

Ray WilliamsĀ is appointed as Manufacturing Manager at the plant in Omaha, NE. Ray has an extensive background in production and operations management of medicinal feed additives with Pfizer and both production management and ingredient merchandizing with various poultry and feed milling companies.

Chad HowserĀ joined the company as Senior Marketing Manager. He will focus on product management for the feed additive business and support to the feed milling and cattle industry segments. Chad holds a BS degree in Marketing and after a sales career in the pharmaceutical industry, spent the last eight years in product management with ADM Alliance Nutrition.

These appointments will position the company well as it enters its next phase of expansion. About Pharmgate and Pharmgate Animal Health Pharmgate LLC, is the majority-owned US subsidiary of Jinhe Biotechnology Co., Ltd., the world leader in the production of chlortetracycline feed grade, chlortetracycline hydrochloride and salinomycin and marketer of PennchlorĀ®, PennoxĀ® and Neo-OxyĀ® brands in the USA.

Pharmgate Animal Health LLC is the joint venture between Pharmgate LLC and ECO Animal Health, London U.K., a leader in the development, registration and marketing of pharmaceutical products for global animal health markets including AivlosinĀ®, as well as a range of generic therapeutic products. PennchlorĀ®, PennoxĀ® and Neo-OxyĀ® are registered trademarks of Pharmgate LLC. AivlosinĀ® is a registered trademark of ECO Animal Health Ltd.

Contact: Pharmgate Animal Health 1 910 679 8364